Back to NewsHow to Sell a Patent Pending Product: 3 RoutesOctober 2026

How to Sell a Patent Pending Product: 3 Routes

If you are working out how to sell a patent pending product, you are really choosing between three different deals. You can sell the product yourself and put the label on the box. You can license it to a company that already makes and ships things. Or you can sell the rights and walk away from the product altogether. All three are legal while the application sits at the patent office. None of them is free. Each one trades away something different before grant, and the first page of search results mostly treats "patent pending" as a sticker rather than a negotiating position. This guide is about the position. ## File before you show it to anyone Every route starts with the same rule, and breaking it closes all three at once. Under first-inventor-to-file, "showing" the product covers more than you might think. Public use, an offer for sale, and a printed publication all count as disclosure, and an offer for sale does not need money to change hands: a price list sent to a distributor or a "coming soon" page is enough. The US one-year grace period is personal to you, so it does not protect you if somebody else publishes or files first, and once 366 days pass without an application you are barred permanently. Outside the US the margin is thinner still. Most countries have no grace period at all, and a US filing gives you patent pending status in the US only. If Germany or the wider EU is part of your market, assume that selling before filing can destroy the novelty the whole application depends on, and get the filing strategy settled before the first sample leaves your hands. Once the application is on file, the order of operations flips. Now delay is the risk, not disclosure. ## Route one: sell the product yourself This is the route most inventors picture, and it is the one where "patent pending" does the most work and the least protecting. ### Marking it correctly You can mark a product patent pending as soon as a provisional, nonprovisional, design or PCT application has actually been filed. A disclosure form sent to an attorney does not count. The marking has to stay accurate: if the application is abandoned or finally rejected, the label comes off everything, including the website and the pitch deck. And if the application covers one feature, say so in substance. Calling a whole platform patent pending when one component is claimed is the kind of statement that reads fine in marketing and badly in litigation. The penalty side is real but narrow. Marking "patent pending" when no application has been made, or when it is no longer pending, is false marking under 35 U.S.C. 292 if done to deceive the public. Statutory damages suits can now only be brought by the government, while a competitor who suffers a competitive injury can sue for compensatory damages, and licensees and contract manufacturers who make the product are expected to mark it correctly too. Put the marking duty in every licence and manufacturing contract you sign. ### What the label does and does not do Be precise with yourself about what you are selling. You can market and sell products marked patent pending, but you cannot sue anyone for copying while the application is pending, and the office usually publishes the application eighteen months after filing. After publication, your claims are public reading for every competitor with an engineer and an afternoon. What the label buys you is signal and timing. It tells customers and investors the work is protected in principle, it gives a would-be copier a reason to hesitate, and it starts building the notice record you will want later. Selling yourself means you keep all the margin and all the risk: manufacturing, inventory, distribution, and the chance that a better-capitalised competitor reads your published application and ships a workaround before you grant. ## Route two: license it to a company that can make it Licensing keeps ownership with you and hands production to someone who already has a factory, a sales team or a distribution channel. It is often the best fit for an inventor with one product and no appetite to become a manufacturer. Expect it to be harder than licensing a granted patent. A practitioner who works these deals says plainly that companies are generally more willing to pay for an issued patent than a pending application, because nobody yet knows the final scope of the claims, and pending licences tend to close when something else is driving the deal, such as market timing, the partner wanting the inventor on board, or a strategic partnership on manufacturing or distribution. The same source lists crowdfunding and small prototype runs as ways to prove demand while you wait, and proven demand is the strongest thing you can bring to a licensing meeting. The contract itself is not weaker because the patent is pending. A licence of a pending application is a binding agreement that sets what the licensee may do, for how long, and what they pay, whether upfront, as royalties, or both. What is uncertain is the asset underneath it, and the odds are not flattering: the allowance rate sits around fifty four percent. So structure around grant risk instead of arguing about it. A lower royalty that steps up on allowance, a modest option fee that converts into a full licence on grant, or a field-of-use licence that leaves you free to license other industries separately. Each one lets the licensee pay for the risk they can see rather than the risk they fear. If you are unsure which shape fits, start with whether to license or sell at all. ## Route three: sell the rights, not the product The third route is to stop selling the product and sell the application. Legally that is clean. Applications for patent are assignable in law by an instrument in writing, and an unrecorded assignment is void against a later good-faith purchaser unless it is recorded within three months or before that later purchase. Commercially it is the hardest of the three. On the buy side, buyers are usually not interested in acquiring individual pending applications until the claims are allowed, because pending applications are generally too speculative to justify value. A product with real sales changes that conversation, because it shows the claims map to something people pay for, but it rarely closes the gap entirely. We cover the mechanics and pricing of selling the application itself separately, along with what changes between pending and issued. If the application is a provisional, you hold something narrower again. A provisional has a twelve month pendency that cannot be extended, is not examined on its merits, and is abandoned automatically if no nonprovisional follows, which is why it pays to understand what a provisional actually transfers before pricing it. ## Protect the waiting period Whichever route you take, the months between filing and grant are where most of the value is won or lost. Use NDAs with partners, even after filing. The application protects what is claimed. The NDA protects the know-how, the tooling details and the business relationship, which is exactly what a manufacturer or licensee sees first. Build the notice record. Pending status carries one real remedy, and it has conditions. Once the patent issues, the owner can recover a reasonable royalty for use between publication and issue, but only where the infringer had actual notice of the published application and the issued claims are substantially identical to the published ones. A well-drafted letter to a copier is how actual notice gets proven later. A label on your own box usually is not. Watch the clocks. A provisional gives you twelve months of pending status. A nonprovisional keeps you pending until grant, abandonment or rejection, and pendency commonly runs two to three years. Put the conversion deadline and every office action response date in the same calendar as your production schedule, because missing one ends the label and the leverage together. Plan for grant. Once the patent issues, the marking switches to the patent number and the commercial rules change again, which is the subject of selling a product once the patent grants. ## How we handle a pending family, including our own We hold a pending family ourselves, so we will not pretend the waiting period is easy. Our first listed family, Edge Assist, is application P00202606645, filed and pending examination, with grant uncertain. We call it a pending application, never a granted patent, because that distinction is what every licensee and buyer will price. The way to narrow the discount is evidence. Before any asset reaches a buyer it passes a validation gate: physics-grade claim reconstruction, detectability analysis and validity probability, benchmarked at 0.76 percent mean absolute percentage error against real-world outcomes. Detectability matters most for a product in the market, because a counterparty who can see how a copy would be proven can price a pending claim set rather than discount it on principle. When we broker a sale or licence for a third party, the incentive is stated up front: commission is paid by the seller on completion, with a minimum fee of EUR 5,000, and no sale means no fee. Rights can be carved by industry, territory or field of use, which is often what makes a pending asset licensable at all. Two limits, in the same breath. EX IX is not a firm of patent attorneys, and a novelty search does not guarantee grant or patentability, so filing and prosecution run through an independent licensed attorney of record. And nobody, us included, can promise a licensee or buyer for a pending product. Anyone who does is selling you certainty the patent office has not issued yet. ## FAQ Can someone copy my patent pending product? Yes, legally they can until the patent issues, because there is no infringement suit before grant. What you keep is a possible claim for a reasonable royalty after grant, if the copier had actual notice of your published application and the final claims stay substantially the same. That is why documented notice matters more than the label. Can I mark my whole product patent pending if the application covers one feature? You can mark the product, but be ready to say which elements the application covers. Keep marketing language either specific to the claimed feature or general, and avoid implying the whole platform is protected. Does a US patent pending label protect my product in Germany or the EU? No. A US application gives pending status in the US only. Protection elsewhere needs corresponding national, European or PCT filings, and because most countries have no grace period, the timing of those filings relative to your first sale matters far more than it does in the US. How long can a product stay patent pending? On a provisional, twelve months, with no extension. On a nonprovisional, until the application is granted, abandoned or finally rejected, which commonly takes two to three years depending on the technology area.

We use essential cookies to operate this website and, with your consent, optional cookies to understand site usage. You can accept or decline non-essential cookies at any time. See our Impressum for our contact and legal details.